(Q44111250)

29 November 2017

Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder (English)

1 reference

29 November 2017

1 reference

1 reference

Michael W Otto

4

0 references

author name string

Mark H Pollack

1

1 reference

29 November 2017

Mark H Rapaport

2

1 reference

29 November 2017

Rana Fayyad

3

1 reference

29 November 2017

Andrew A Nierenberg

5

1 reference

29 November 2017

Cathryn M Clary

6

1 reference

29 November 2017

1 July 2002

1 reference

Journal of Psychiatric Research

29 November 2017

1 reference

29 November 2017

36

1 reference

29 November 2017

229-236

1 reference

29 November 2017

4

1 reference

Drug treatment of panic disorder: early response to treatment as a predictor of final outcome

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

The assessment of anxiety states by rating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Development of a Rating Scale for Primary Depressive Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Diagnosing diagnoses. Receiver operating characteristic methods and psychiatry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Basic principles of ROC analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Early nonresponse to fluoxetine as a predictor of poor 8-week outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Initial response to active drug and placebo predicts outcome of antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Can the effects of antidepressants be observed in the first two weeks of treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Is placebo response the same as drug response in panic disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2802%2900010-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(02)00010-9

1 reference

29 November 2017

1 reference